Ravi Sachdev

Mr. Sachdev joined CD&R in 2015. He played a key role in the Firm’s investments in agilon health, naviHealth, TRANZACT, and Covetrus. Previously, he served as a managing director and co-head of healthcare services at J.P. Morgan, advising senior healthcare company executives on strategic initiatives, M&A, and capital markets. In that role, Mr. Sachdev advised on multiple transactions including the sale of Medco to Express Scripts, Vanguard to Tenet, Trizetto to Cognizant, and the IPOs of HealthEquity, SCA, Premier, and IMS Health. He serves on the board of the Healthcare Private Equity Association.